Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Increased circulation refers broadly to the state of elevated blood flow in a tissue, organ, or the whole body. This process is mediated by a variety of molecular targets, pathways, and cellular mechanisms including vasodilation (widening of blood vessels), increased cardiac output, and changes in microvascular tone. Key mediators include adenosine, nitric oxide (NO), prostaglandins, and signaling through receptors such as beta-adrenergic receptors, angiotensin II type 1 receptor (AT1R), and Mas receptor. The regulation of blood flow is essential for oxygen and nutrient delivery, metabolic waste removal, temperature control, and responses to injury or disease. Increased circulation is not a discrete molecular entity, receptor, enzyme, or transporter but rather the sum effect of multiple regulatory systems acting together[1][3][4][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Increased circulation.